Skip to main content
Themis Medicare Ltd. logo

Themis Medicare Ltd. — Investor Relations & Filings

Ticker · THEMISMED ISIN · INE083B01024 LEI · 335800LHRDVIKH69AF42 BSE.NS Manufacturing
Open in API
Filings indexed 707 across all filing types
Latest filing 2023-10-19 Audit Report / Informat…
Country IN India
Listing BSE.NS THEMISMED

About Themis Medicare Ltd.

https://www.themismedicare.com/

Themis Medicare Ltd. is a research-driven pharmaceutical organization specializing in the development, manufacture, and marketing of a diverse range of therapeutic products. The company focuses on high-value segments including pain management, anesthesia, critical care, anti-infectives, and oncology. Its core competencies lie in the production of Active Pharmaceutical Ingredients (APIs) and complex finished dosage formulations, particularly injectables. Themis Medicare maintains a strong emphasis on Research and Development, operating state-of-the-art facilities that adhere to international quality standards such as WHO-GMP. Through strategic partnerships and a robust supply chain, the company serves both domestic and international markets, providing specialized medical solutions for hospital-based care and chronic disease management. Its portfolio includes proprietary delivery systems and differentiated generic products designed to improve patient outcomes.

Recent filings

Filing Released Lang Actions
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Audit Report / Information Classification · 95% confidence The document is titled 'Reconciliation of Share Capital Audit Report for the quarter ended 30th September, 2023' and references Regulation 76 of SEBI (Depositories and Participants) Regulations, 2018. It is a letter enclosing the Reconciliation of Share Capital Audit Report for a specific quarter. The document length is short (1494 characters) and it is a communication submitting the audit report to the stock exchanges. This type of document is a standalone audit report related to share capital reconciliation, which fits the category 'Audit Report / Information (AR)'. It is not an Annual Report or Interim Report as it does not contain full financial statements or management discussion. It is not a report publication announcement since it contains the actual audit report content or summary. Therefore, the correct classification is AR with high confidence.
2023-10-19 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the publication of a newspaper advertisement for a postal ballot notice, pursuant to Regulation 47 of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. It includes a copy of the newspaper advertisement and related tender notices and public announcements. There is no detailed financial data, management discussion, or report content. The document is an announcement of a notice publication rather than the notice or report itself. Therefore, it fits the category of Regulatory Filings (RNS), which covers general regulatory announcements and miscellaneous filings that do not fit other categories.
2023-10-17 English
Shareholders meeting
Regulatory Filings Classification · 95% confidence The document is a Notice of Postal Ballot and E-voting issued by Themis Medicare Limited dated 7th September 2023, with details about the voting process, cut-off dates, and resolutions to be passed by shareholders. It includes appointment of directors and procedural information for shareholders to vote remotely. The document is not a report itself but a notice seeking shareholder approval via postal ballot. It does not contain financial statements or results but is a formal communication related to shareholder voting. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or closely related notices. However, since this is the notice of the postal ballot and voting process, not the results, it is best classified as a Regulatory Filing (RNS) because it is a regulatory announcement about the voting process and not the actual voting results or report. The document length is substantial but it is a notice, not a report or results announcement. Hence, Regulatory Filings (RNS) is the most appropriate classification.
2023-10-16 English
Reply to Clarification Sought
Capital/Financing Update Classification · 95% confidence The document is a formal communication addressed to stock exchanges (BSE and NSE) regarding the incorporation of a wholly owned subsidiary named 'Rx Themis Private Limited'. It references compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content includes details about the subsidiary, such as shareholding, industry, and consideration paid, but does not contain financial statements or detailed financial analysis. The document is an announcement of a corporate event (incorporation of a subsidiary) rather than a financial report or detailed management discussion. Therefore, it fits best under Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes, including incorporation of subsidiaries.
2023-10-16 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a short letter addressed to stock exchanges (BSE and NSE) dated October 9, 2023. It references a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2023. The document states that the certificate is enclosed and is for information and record purposes. There is no financial data, no detailed report content, and the document is only a certification submission. According to the CERTIFICATION RULE, such officer certifications or attestations, even if referencing a quarterly period, should be classified as Regulatory Filings (RNS). The document length is short (1532 characters), and it is not the report itself but a certification related to regulatory compliance.
2023-10-09 English
Trading Window
Regulatory Filings Classification · 100% confidence The document is a notification addressed to stock exchanges regarding the closure of the trading window in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. It informs about the trading window closure period related to the upcoming financial results announcement for the quarter and half year ended 30th September 2023. The document does not contain any financial data, results, or detailed report but is an announcement related to regulatory compliance and trading restrictions. The document length is short (2440 characters) and it is clearly an announcement rather than a report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-09-28 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.